NewsRx

Search our medical news database

Advancis Pharmaceutical Corporation

Keflex powder for oral suspension launched in the United States

Published in Law and Health Weekly, July 9th, 2005

Advancis Pharmaceutical Corporation (AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, announced that it has launched Keflex Powder for Oral Suspension (cephalexin, USP).

The launch marks the return of Keflex to pharmacy shelves. Keflex Powder for Oral Suspension is available in two strengths and two bottle sizes.

"We are pleased to offer Keflex to customers once again. Pediatricians and parents understand how challenging it can be to administer antibiotic therapy to pediatric patients. We are hopeful that the appealing flavor of Keflex will improve patient cooperation and compliance," stated...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook